• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CHM

CHIMERIC THERAPEUTICS LIMITED - Announcements

25.0% ! 0.3¢
Market Cap $9.747M  !

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company,... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company, focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its diversified portfolio includes first-in-class autologous CAR T cell therapies and allogeneic natural killer (NK) cell therapies. Its assets are being developed across multiple different disease areas in oncology with four clinical stage programs. Its pipeline includes CHM CDH17, CHM CLTX and CHM CORE NK platform. CHM CDH17 is a third-generation CDH17 CAR T, which is in phase I/II clinical trial in gastrointestinal and neuroendocrine tumors. CHM CORE-NK is a clinically validated NK cell platform in phase IB clinical trials investigating CORE-NK in combination regimens. CHM CLTX is a novel CAR-T therapy developed for the treatment of patients with solid tumors. CLTX CAR T is in phase IB clinical trial in recurrent/progressive glioblastoma. It is also building a Cell therapy portfolio.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



CHM Dr Stephanie H. Astrow appointed VP, Translational Sciences08/09/22 download Created with Sketch. 170.37KB
CHM Appendix 4E and Preliminary Final ReportPRICE SENSITIVE31/08/22 download Created with Sketch. 250.23KB
CHM Response to ASX Query09/08/22 download Created with Sketch. 206.86KB
CHM Patent received in Japan for CLTX CAR technologyPRICE SENSITIVE03/08/22 download Created with Sketch. 167.54KB
CHM Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE29/07/22 download Created with Sketch. 1.06MB
CHM Cell therapy industry leader appointed Chief Medical Officer25/07/22 download Created with Sketch. 198.06KB
CHM Change of Director's Interest Notice - GM07/07/22 download Created with Sketch. 183.88KB
CHM Appointment of VP Clinical Operations & Data Management05/07/22 download Created with Sketch. 171.21KB
CHM Change of Director's Interest Notice - LC30/06/22 download Created with Sketch. 171.15KB
CHM Application for quotation of securities - CHM29/06/22 download Created with Sketch. 26.71KB
CHM Licenses viral vector technology from Penn for CDH17PRICE SENSITIVE29/06/22 download Created with Sketch. 170.33KB
CHM Notification regarding unquoted securities - CHM27/06/22 download Created with Sketch. 41.13KB
CHM First phase 1B trial of NK cells with IL-2 & Vactosertib24/06/22 download Created with Sketch. 260.36KB
CHM Notice under section 708A21/06/22 download Created with Sketch. 180.29KB
CHM Notification regarding unquoted securities - CHM15/06/22 download Created with Sketch. 30.37KB
CHM Application for quotation of securities - CHM15/06/22 download Created with Sketch. 26.65KB
CHM Key manufacturing milestone successfully completed10/06/22 download Created with Sketch. 193.07KB
CHM Proposed issue of securities - CHM09/06/22 download Created with Sketch. 29.44KB
CHM A$30 million Equity Placement Agreement with L1 CapitalPRICE SENSITIVE09/06/22 download Created with Sketch. 212.19KB
CHM Notification of cessation of securities - CHM27/05/22 download Created with Sketch. 23.26KB
CHM Exclusive option exercised for CORE-NK platform25/05/22 download Created with Sketch. 167.59KB
CHM Virtual investor conference presentation 2 May 202228/04/22 download Created with Sketch. 168.22KB
CHM Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE27/04/22 download Created with Sketch. 1.61MB
CHM Strategic manufacturing partnership with WuXi ATUPRICE SENSITIVE12/04/22 download Created with Sketch. 201.19KB
CHM Change of Director's Interest Notice - GM30/03/22 download Created with Sketch. 227.45KB
CHM Change of Director's Interest Notice - CE30/03/22 download Created with Sketch. 225.95KB
CHM Change of Director's Interest Notice - PH30/03/22 download Created with Sketch. 206.56KB
CHM Change of Director's Interest Notice - LC30/03/22 download Created with Sketch. 224.46KB
CHM Appendix 2A30/03/22 download Created with Sketch. 385.14KB
CHM Security Class Reinstatement to Quotation CHMOPRICE SENSITIVE28/03/22 download Created with Sketch. 86.75KB
CHM Entitlement Offer Option Exercise Form25/03/22 download Created with Sketch. 286.01KB
CHM Appendix 2A (amended)25/03/22 download Created with Sketch. 550.93KB
CHM Appendix 2A25/03/22 download Created with Sketch. 386.46KB
CHM Placement of Entitlement Offer ShortfallPRICE SENSITIVE25/03/22 download Created with Sketch. 217.63KB
CHM CDH17 CAR T PRECLINICAL DATA FEATURED IN NATURE CANCERPRICE SENSITIVE23/03/22 download Created with Sketch. 239.86KB
CHM Trading HaltPRICE SENSITIVE23/03/22 download Created with Sketch. 254.81KB
CHM Pause in TradingPRICE SENSITIVE23/03/22 download Created with Sketch. 116.96KB
CHM Completion of retail component of Entitlement OfferPRICE SENSITIVE23/03/22 download Created with Sketch. 136.02KB
CHM Security Class Suspension from Quotation CHMOPRICE SENSITIVE21/03/22 download Created with Sketch. 90.85KB
CHM Appendix 3B (amended)08/03/22 download Created with Sketch. 864.35KB
CHM Extension of Closing Date for Retail Entitlement Offer08/03/22 download Created with Sketch. 150.02KB
CHM Final Results in Phase 1 Trial of CORE NK PlatformPRICE SENSITIVE07/03/22 download Created with Sketch. 446.36KB
CHM CORE NK Platform Phase 1 Clinical Data Presentation07/03/22 download Created with Sketch. 807.11KB
CHM CHIMERIC PARTNERS WITH BE THE MATCH BIOTHERAPIESPRICE SENSITIVE04/03/22 download Created with Sketch. 291.69KB
CHM Change in substantial holding - PH03/03/22 download Created with Sketch. 181.39KB
CHM Change of Director's Interest Notice - PH03/03/22 download Created with Sketch. 419.4KB
CHM Entitlement Offer Notice to Eligible Retail Shareholders28/02/22 download Created with Sketch. 134.3KB
CHM Entitlement Offer Notice to Ineligible Retail Shareholders28/02/22 download Created with Sketch. 126.76KB
CHM Appendix 2A28/02/22 download Created with Sketch. 411.15KB
CHM Half Yearly Report and AccountsPRICE SENSITIVE28/02/22 download Created with Sketch. 1.76MB
CHM Successful completion of Institutional Entitlement OfferPRICE SENSITIVE23/02/22 download Created with Sketch. 166.41KB
CHM Appendix 3B (amended)22/02/22 download Created with Sketch. 1.08MB
CHM Investor Presentation - Entitlement Offer22/02/22 download Created with Sketch. 3.51MB
CHM ProspectusPRICE SENSITIVE21/02/22 download Created with Sketch. 987.05KB
CHM Appendix 3B21/02/22 download Created with Sketch. 691.47KB
CHM Entitlement Offer to raise approximately $18.1 millionPRICE SENSITIVE21/02/22 download Created with Sketch. 277.48KB
CHM Trading HaltPRICE SENSITIVE21/02/22 download Created with Sketch. 254.51KB
CHM 2nd dose cohort in CLTX CAR T (supplementary announcement)15/02/22 download Created with Sketch. 188.09KB
CHM Research Agreement with Penn (supplementary announcement)15/02/22 download Created with Sketch. 186.65KB
CHM Encouraging data from 2nd dose cohort in CLTX CAR T trialPRICE SENSITIVE08/02/22 download Created with Sketch. 254.56KB
CHM Notification regarding unquoted securities - CHM07/02/22 download Created with Sketch. 29.16KB
CHM Kelly Thornburg appointed Vice President, Head of Quality03/02/22 download Created with Sketch. 233.01KB
CHM Sponsored Research Agreement with University of PennsylvaniaPRICE SENSITIVE01/02/22 download Created with Sketch. 229.89KB
CHM Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE27/01/22 download Created with Sketch. 1.59MB
CHM Chimeric receives US patent covering CLTX CAR technologyPRICE SENSITIVE27/01/22 download Created with Sketch. 168.64KB
CHM Response to Appendix 3Y Query14/01/22 download Created with Sketch. 240.67KB
CHM Successful completion of 2nd dose cohort in CLTX CAR T trial17/12/21 download Created with Sketch. 254.63KB
CHM Change of Director's Interest Notice - JC, CE & GM14/12/21 download Created with Sketch. 437.63KB
CHM Key management changes for 202213/12/21 download Created with Sketch. 172.24KB
CHM Change in substantial holding - PH08/12/21 download Created with Sketch. 219.8KB
CHM Change of Director's Interest Notice - PH08/12/21 download Created with Sketch. 200.18KB
CHM CORE-NK CELL PLATFORM (supplementary announcement)07/12/21 download Created with Sketch. 164.03KB
CHM Application for quotation of securities - CHM06/12/21 download Created with Sketch. 26.44KB
CHM Notification regarding unquoted securities - CHM03/12/21 download Created with Sketch. 50.55KB
CHM Application for quotation of securities - CHM03/12/21 download Created with Sketch. 25.51KB
CHM Transformative Portfolio Expansion PresentationPRICE SENSITIVE01/12/21 download Created with Sketch. 6.17MB
CHM Webinar CHM Transforms PortfolioPRICE SENSITIVE01/12/21 download Created with Sketch. 276KB
CHM Results of Meeting22/11/21 download Created with Sketch. 296.23KB
CHM AGM Presentation22/11/21 download Created with Sketch. 1.81MB
CHM CLTX CAR T data shows regional control of tumour recurrencePRICE SENSITIVE22/11/21 download Created with Sketch. 287.49KB
CHM CLTX CAR T PRESENTS POSITIVE INITIAL PHASE 1 CLINICAL DATAPRICE SENSITIVE15/11/21 download Created with Sketch. 284.43KB
CHM FIRST MILESTONE ON PATH TO CDH17 CAR T CLINICAL TRIALPRICE SENSITIVE22/10/21 download Created with Sketch. 213.94KB
CHM Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE21/10/21 download Created with Sketch. 3.16MB
CHM Notice of Annual General Meeting/Proxy Form18/10/21 download Created with Sketch. 1.09MB
CHM Corporate Governance Statement29/09/21 download Created with Sketch. 185.23KB
CHM Appendix 4G29/09/21 download Created with Sketch. 256.17KB
CHM Annual Report to shareholders29/09/21 download Created with Sketch. 7.91MB
CHM CHM 1101 data accepted for presentation at SNO meeting29/09/21 download Created with Sketch. 253.18KB
CHM Notification regarding unquoted securities - CHM23/09/21 download Created with Sketch. 27.31KB
CHM European patent granted for CLTX technology used in CHM 1101PRICE SENSITIVE23/09/21 download Created with Sketch. 204.23KB
CHM Cellular therapy experts join Chimeric CI-SAB15/09/21 download Created with Sketch. 196.25KB
CHM Partnership with OncoBay Clinical to advance CHM 1101PRICE SENSITIVE02/09/21 download Created with Sketch. 214.42KB
CHM Initial Director's Interest Notice - JC02/09/21 download Created with Sketch. 163.96KB
CHM Notice under section 708A31/08/21 download Created with Sketch. 152.16KB
CHM Preliminary Final ReportPRICE SENSITIVE31/08/21 download Created with Sketch. 228.58KB
CHM Chimeric Appoints Jennifer Chow as CEO & MDPRICE SENSITIVE30/08/21 download Created with Sketch. 221.79KB
CHM Notification regarding unquoted securities - CHM27/08/21 download Created with Sketch. 35.68KB
CHM Application for quotation of securities - CHM27/08/21 download Created with Sketch. 29.41KB
CHM Application for quotation of securities - CHM25/08/21 download Created with Sketch. 24.64KB
CHM Release of ordinary shares from escrow25/08/21 download Created with Sketch. 153.88KB
CHM Dr Stephanie H. Astrow appointed VP, Translational Sciences
08/09/22 download Created with Sketch. 170.37KB
CHM Appendix 4E and Preliminary Final Report
31/08/22PRICE SENSITIVE download Created with Sketch. 250.23KB
CHM Response to ASX Query
09/08/22 download Created with Sketch. 206.86KB
CHM Patent received in Japan for CLTX CAR technology
03/08/22PRICE SENSITIVE download Created with Sketch. 167.54KB
CHM Quarterly Activities/Appendix 4C Cash Flow Report
29/07/22PRICE SENSITIVE download Created with Sketch. 1.06MB
CHM Cell therapy industry leader appointed Chief Medical Officer
25/07/22 download Created with Sketch. 198.06KB
CHM Change of Director's Interest Notice - GM
07/07/22 download Created with Sketch. 183.88KB
CHM Appointment of VP Clinical Operations & Data Management
05/07/22 download Created with Sketch. 171.21KB
CHM Change of Director's Interest Notice - LC
30/06/22 download Created with Sketch. 171.15KB
CHM Application for quotation of securities - CHM
29/06/22 download Created with Sketch. 26.71KB
CHM Licenses viral vector technology from Penn for CDH17
29/06/22PRICE SENSITIVE download Created with Sketch. 170.33KB
CHM Notification regarding unquoted securities - CHM
27/06/22 download Created with Sketch. 41.13KB
CHM First phase 1B trial of NK cells with IL-2 & Vactosertib
24/06/22 download Created with Sketch. 260.36KB
CHM Notice under section 708A
21/06/22 download Created with Sketch. 180.29KB
CHM Notification regarding unquoted securities - CHM
15/06/22 download Created with Sketch. 30.37KB
CHM Application for quotation of securities - CHM
15/06/22 download Created with Sketch. 26.65KB
CHM Key manufacturing milestone successfully completed
10/06/22 download Created with Sketch. 193.07KB
CHM Proposed issue of securities - CHM
09/06/22 download Created with Sketch. 29.44KB
CHM A$30 million Equity Placement Agreement with L1 Capital
09/06/22PRICE SENSITIVE download Created with Sketch. 212.19KB
CHM Notification of cessation of securities - CHM
27/05/22 download Created with Sketch. 23.26KB
CHM Exclusive option exercised for CORE-NK platform
25/05/22 download Created with Sketch. 167.59KB
CHM Virtual investor conference presentation 2 May 2022
28/04/22 download Created with Sketch. 168.22KB
CHM Quarterly Activities/Appendix 4C Cash Flow Report
27/04/22PRICE SENSITIVE download Created with Sketch. 1.61MB
CHM Strategic manufacturing partnership with WuXi ATU
12/04/22PRICE SENSITIVE download Created with Sketch. 201.19KB
CHM Change of Director's Interest Notice - GM
30/03/22 download Created with Sketch. 227.45KB
CHM Change of Director's Interest Notice - CE
30/03/22 download Created with Sketch. 225.95KB
CHM Change of Director's Interest Notice - PH
30/03/22 download Created with Sketch. 206.56KB
CHM Change of Director's Interest Notice - LC
30/03/22 download Created with Sketch. 224.46KB
CHM Appendix 2A
30/03/22 download Created with Sketch. 385.14KB
CHM Security Class Reinstatement to Quotation CHMO
28/03/22PRICE SENSITIVE download Created with Sketch. 86.75KB
CHM Entitlement Offer Option Exercise Form
25/03/22 download Created with Sketch. 286.01KB
CHM Appendix 2A (amended)
25/03/22 download Created with Sketch. 550.93KB
CHM Appendix 2A
25/03/22 download Created with Sketch. 386.46KB
CHM Placement of Entitlement Offer Shortfall
25/03/22PRICE SENSITIVE download Created with Sketch. 217.63KB
CHM CDH17 CAR T PRECLINICAL DATA FEATURED IN NATURE CANCER
23/03/22PRICE SENSITIVE download Created with Sketch. 239.86KB
CHM Trading Halt
23/03/22PRICE SENSITIVE download Created with Sketch. 254.81KB
CHM Pause in Trading
23/03/22PRICE SENSITIVE download Created with Sketch. 116.96KB
CHM Completion of retail component of Entitlement Offer
23/03/22PRICE SENSITIVE download Created with Sketch. 136.02KB
CHM Security Class Suspension from Quotation CHMO
21/03/22PRICE SENSITIVE download Created with Sketch. 90.85KB
CHM Appendix 3B (amended)
08/03/22 download Created with Sketch. 864.35KB
CHM Extension of Closing Date for Retail Entitlement Offer
08/03/22 download Created with Sketch. 150.02KB
CHM Final Results in Phase 1 Trial of CORE NK Platform
07/03/22PRICE SENSITIVE download Created with Sketch. 446.36KB
CHM CORE NK Platform Phase 1 Clinical Data Presentation
07/03/22 download Created with Sketch. 807.11KB
CHM CHIMERIC PARTNERS WITH BE THE MATCH BIOTHERAPIES
04/03/22PRICE SENSITIVE download Created with Sketch. 291.69KB
CHM Change in substantial holding - PH
03/03/22 download Created with Sketch. 181.39KB
CHM Change of Director's Interest Notice - PH
03/03/22 download Created with Sketch. 419.4KB
CHM Entitlement Offer Notice to Eligible Retail Shareholders
28/02/22 download Created with Sketch. 134.3KB
CHM Entitlement Offer Notice to Ineligible Retail Shareholders
28/02/22 download Created with Sketch. 126.76KB
CHM Appendix 2A
28/02/22 download Created with Sketch. 411.15KB
CHM Half Yearly Report and Accounts
28/02/22PRICE SENSITIVE download Created with Sketch. 1.76MB
CHM Successful completion of Institutional Entitlement Offer
23/02/22PRICE SENSITIVE download Created with Sketch. 166.41KB
CHM Appendix 3B (amended)
22/02/22 download Created with Sketch. 1.08MB
CHM Investor Presentation - Entitlement Offer
22/02/22 download Created with Sketch. 3.51MB
CHM Prospectus
21/02/22PRICE SENSITIVE download Created with Sketch. 987.05KB
CHM Appendix 3B
21/02/22 download Created with Sketch. 691.47KB
CHM Entitlement Offer to raise approximately $18.1 million
21/02/22PRICE SENSITIVE download Created with Sketch. 277.48KB
CHM Trading Halt
21/02/22PRICE SENSITIVE download Created with Sketch. 254.51KB
CHM 2nd dose cohort in CLTX CAR T (supplementary announcement)
15/02/22 download Created with Sketch. 188.09KB
CHM Research Agreement with Penn (supplementary announcement)
15/02/22 download Created with Sketch. 186.65KB
CHM Encouraging data from 2nd dose cohort in CLTX CAR T trial
08/02/22PRICE SENSITIVE download Created with Sketch. 254.56KB
CHM Notification regarding unquoted securities - CHM
07/02/22 download Created with Sketch. 29.16KB
CHM Kelly Thornburg appointed Vice President, Head of Quality
03/02/22 download Created with Sketch. 233.01KB
CHM Sponsored Research Agreement with University of Pennsylvania
01/02/22PRICE SENSITIVE download Created with Sketch. 229.89KB
CHM Quarterly Activities/Appendix 4C Cash Flow Report
27/01/22PRICE SENSITIVE download Created with Sketch. 1.59MB
CHM Chimeric receives US patent covering CLTX CAR technology
27/01/22PRICE SENSITIVE download Created with Sketch. 168.64KB
CHM Response to Appendix 3Y Query
14/01/22 download Created with Sketch. 240.67KB
CHM Successful completion of 2nd dose cohort in CLTX CAR T trial
17/12/21 download Created with Sketch. 254.63KB
CHM Change of Director's Interest Notice - JC, CE & GM
14/12/21 download Created with Sketch. 437.63KB
CHM Key management changes for 2022
13/12/21 download Created with Sketch. 172.24KB
CHM Change in substantial holding - PH
08/12/21 download Created with Sketch. 219.8KB
CHM Change of Director's Interest Notice - PH
08/12/21 download Created with Sketch. 200.18KB
CHM CORE-NK CELL PLATFORM (supplementary announcement)
07/12/21 download Created with Sketch. 164.03KB
CHM Application for quotation of securities - CHM
06/12/21 download Created with Sketch. 26.44KB
CHM Notification regarding unquoted securities - CHM
03/12/21 download Created with Sketch. 50.55KB
CHM Application for quotation of securities - CHM
03/12/21 download Created with Sketch. 25.51KB
CHM Transformative Portfolio Expansion Presentation
01/12/21PRICE SENSITIVE download Created with Sketch. 6.17MB
CHM Webinar CHM Transforms Portfolio
01/12/21PRICE SENSITIVE download Created with Sketch. 276KB
CHM Results of Meeting
22/11/21 download Created with Sketch. 296.23KB
CHM AGM Presentation
22/11/21 download Created with Sketch. 1.81MB
CHM CLTX CAR T data shows regional control of tumour recurrence
22/11/21PRICE SENSITIVE download Created with Sketch. 287.49KB
CHM CLTX CAR T PRESENTS POSITIVE INITIAL PHASE 1 CLINICAL DATA
15/11/21PRICE SENSITIVE download Created with Sketch. 284.43KB
CHM FIRST MILESTONE ON PATH TO CDH17 CAR T CLINICAL TRIAL
22/10/21PRICE SENSITIVE download Created with Sketch. 213.94KB
CHM Quarterly Activities/Appendix 4C Cash Flow Report
21/10/21PRICE SENSITIVE download Created with Sketch. 3.16MB
CHM Notice of Annual General Meeting/Proxy Form
18/10/21 download Created with Sketch. 1.09MB
CHM Corporate Governance Statement
29/09/21 download Created with Sketch. 185.23KB
CHM Appendix 4G
29/09/21 download Created with Sketch. 256.17KB
CHM Annual Report to shareholders
29/09/21 download Created with Sketch. 7.91MB
CHM CHM 1101 data accepted for presentation at SNO meeting
29/09/21 download Created with Sketch. 253.18KB
CHM Notification regarding unquoted securities - CHM
23/09/21 download Created with Sketch. 27.31KB
CHM European patent granted for CLTX technology used in CHM 1101
23/09/21PRICE SENSITIVE download Created with Sketch. 204.23KB
CHM Cellular therapy experts join Chimeric CI-SAB
15/09/21 download Created with Sketch. 196.25KB
CHM Partnership with OncoBay Clinical to advance CHM 1101
02/09/21PRICE SENSITIVE download Created with Sketch. 214.42KB
CHM Initial Director's Interest Notice - JC
02/09/21 download Created with Sketch. 163.96KB
CHM Notice under section 708A
31/08/21 download Created with Sketch. 152.16KB
CHM Preliminary Final Report
31/08/21PRICE SENSITIVE download Created with Sketch. 228.58KB
CHM Chimeric Appoints Jennifer Chow as CEO & MD
30/08/21PRICE SENSITIVE download Created with Sketch. 221.79KB
CHM Notification regarding unquoted securities - CHM
27/08/21 download Created with Sketch. 35.68KB
CHM Application for quotation of securities - CHM
27/08/21 download Created with Sketch. 29.41KB
CHM Application for quotation of securities - CHM
25/08/21 download Created with Sketch. 24.64KB
CHM Release of ordinary shares from escrow
25/08/21 download Created with Sketch. 153.88KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.3¢
Change
-0.001(25.0%)
Mkt cap ! $9.747M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $11.33K 3.775M

Buyers (Bids)

No. Vol. Price($)
75 71644408 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 87927011 26
View Market Depth
Last trade - 14.48pm 31/07/2025 (20 minute delay) ?
Last
0.4¢
  Change
-0.001 ( 16.7 %)
Open High Low Volume
0.4¢ 0.4¢ 0.3¢ 568204
Last updated 12.29pm 31/07/2025 ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.